France's IMPLANET H1 revenue rises on medical equipment strength, US growth

Implanet SA

15/09/2026 16:58

Overview
France medical implants maker's H1 revenue rose 23% yr/yr to €7.1 mln
Gross margin improved by 7 points to 59.5%, driven by JSS system and US growth
Operating loss narrowed by 13% despite higher commercial investments

Outlook
IMPLANET plans to reinforce its U.S. commercial team and accelerate JAZZ rollout
Company aims to expand JAZZ platform distribution in China with Sanyou Medical
IMPLANET intends to launch SMTP Quntas ultrasonic scalpels for surgical revision and tumor surgery

Result Drivers
JSS SYSTEM SALES - Co said strong performance of new JSS hybrid posterior fixation system drove spine implant revenue, with associated sales doubling yr/yr
MEDICAL EQUIPMENT GROWTH - Co said continued rollout of medical equipment distribution, notably SMTP ultrasonic scalpel, lifted segment revenue 27% yr/yr
US EXPANSION - Co said US revenue rose 54% yr/yr, driven by strong JSS system sales and expanded commercial activities

Company press release: ID:nBw1jhbKxa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
EUR 7.1 mln
 
H1 Net Loss
 
EUR 2.14 mln
 
H1 Operating Income
 
-EUR 1.87 mln
 

Reuters Recommended Reads
Sept 15 - UK's IP Group HY26 NAV/share rises on Pfizer obesity programme progress
Sept 14 - Kestra Medical Technologies Q1 revenue beats estimates, raises FY revenue outlook
Sept 14 - Hain Celestial Q4 sales miss estimates on divestiture impact

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)